The MDP 301 microbicide trial used multiple approaches at the Masaka site to mobilise and sensitise the community, get feedback, share information, and communicate the final trial results.

A free ARV programme implemented with support from external donors has over the past few years led to a significant increase in the number of people living with HIV/AIDS (PHAs) accessing antiretroviral therapy (ART)